52328-48-0 Usage
Uses
Used in Chemical Synthesis:
4-tert-Butyl-2-methoxybenzoic acid is used as a chemical intermediate for the synthesis of various organic compounds. Its unique structure allows it to be a key component in the production of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Pharmaceutical Industry:
4-tert-Butyl-2-methoxybenzoic acid is used as a building block for the development of new drugs. Its chemical properties make it a valuable asset in the creation of novel therapeutic agents, potentially leading to advancements in medicine.
Used in Material Science:
4-tert-Butyl-2-methoxybenzoic acid is used as a component in the formulation of new materials, such as polymers and coatings. Its incorporation can enhance the properties of these materials, leading to improved performance in various applications.
Used in Research and Development:
4-tert-Butyl-2-methoxybenzoic acid is used as a research compound for studying its chemical properties and potential applications. This can lead to a better understanding of its behavior and the development of new uses in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 52328-48-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,3,2 and 8 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 52328-48:
(7*5)+(6*2)+(5*3)+(4*2)+(3*8)+(2*4)+(1*8)=110
110 % 10 = 0
So 52328-48-0 is a valid CAS Registry Number.
InChI:InChI=1/C12H16O3/c1-12(2,3)8-5-6-9(11(13)14)10(7-8)15-4/h5-7H,1-4H3,(H,13,14)
52328-48-0Relevant articles and documents
SUBSTITUTED BIPIPERIDINYL DERIVATIVES
-
Paragraph 0595; 0596; 0597; 0598, (2016/11/17)
The invention relates to novel substituted bipiperidinyl derivatives, to processes for their preparation, to their use for the treatment and/or prevention of diseases and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of diabetic microangiopathies, diabetic ulcers on the extremities, in particular for promoting wound healing of diabetic foot ulcers, diabetic heart failure, diabetic coronary microvascular heart disorders, peripheral and cardiac vascular disorders, thromboembolic disorders and ischaemias, peripheral circulatory disturbances, Raynaud's phenomenon, CREST syndrome, microcirculatory disturbances, intermittent claudication, and peripheral and autonomous neuropathies.
